April 15, 2014 — The Spectranetics Corp. announced U.S. Food and Drug Administration (FDA) clearance of two new ...
March 7, 2014 — The Spectranetics Corp. announced that the Excite ISR trial achieved the statistical endpoints of the ...
January 24, 2013 — The Spectranetics Corporation announced final results from the PATENT (Photo-Ablation using the TURBO ...
January 8, 2013 — Spectranetics Corp. announced an agreement to purchase the assets of Upstream Peripheral Technologies ...
October 11, 2012 — Spectranetics Corp. announced the U.S. market launch of the Tapas catheter at the 2012 Vascular ...
Atherectomy devices are used in the cath lab to debulk lesions by cutting or laser ablating plaque, calcium and tissue ...
May 2, 2012 — The Spectranetics Corp. announced U.S. Food and Drug Administration (FDA) approval of the new advanced ...
Cardiac rhythm device reliability and the approach to managing complications associated with these devices have recently ...
June 11, 2010 – A multicenter, randomized trial planned in the United States will compare laser ablation followed by ...
May 13, 2010 – A new simulation system to augment traditional procedural training for physicians on laser-assisted lead ...